Retatrutide is a new medication in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By boosting these receptors, https://esmeeutwm075076.dgbloggers.com/36650589/tirzepatide-a-promising-new-treatment-for-obesity